Dong Wang

机构：First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · ORCID：0000-0002-7539-9963

发表论文 30 篇 · 总被引 293 次 · h-index 10

代表论文

• GADD45α sensitizes cervical cancer cells to radiotherapy via increasing cytoplasmic APE1 level (2018 · Cell Death and Disease · 被引 40)
• Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review (2022 · Biomedicine & Pharmacotherapy · 被引 35)
• Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression (2023 · Genes & Diseases · 被引 34)
• Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study (2021 · BioDrugs · 被引 29)
• The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention (2022 · Biomedicine & Pharmacotherapy · 被引 26)
• Progress in the study of molecular mechanisms of cell pyroptosis in tumor therapy (2023 · International Immunopharmacology · 被引 25)